High expression of SLC2A1 has been found to be connected with inferior outcomes in various adult malignancies, including liver cancer (Chen et al., 2018), lung cancer (Zhang et al., 2019), breast cancer (Deng et al., 2018), colorectal cancer (Yang et al., 2017), and so on. The gene discussed is SLC2A1; the disease is breast carcinoma.